Epidemiology of pancreatic cancer: an overview - PubMed (original) (raw)
Review
. 2009 Dec;6(12):699-708.
doi: 10.1038/nrgastro.2009.177. Epub 2009 Oct 6.
Affiliations
- PMID: 19806144
- DOI: 10.1038/nrgastro.2009.177
Review
Epidemiology of pancreatic cancer: an overview
Sara Raimondi et al. Nat Rev Gastroenterol Hepatol. 2009 Dec.
Abstract
Pancreatic cancer, although infrequent, has an exceptionally high mortality rate, making it one of the four or five most common causes of cancer mortality in developed countries. The incidence of pancreatic cancer varies greatly across regions, which suggests roles for lifestyle factors, such as diet, or environmental factors, such as vitamin D exposure. Smoking is the most common known risk factor, and is the cause of 20-25% of all pancreatic tumors. Alcohol does not seem to be a risk factor, unless it leads to chronic pancreatitis, which is a probable risk factor. Long-standing diabetes increases the risk of pancreatic cancer, but can also be an early manifestation of pancreatic tumors. 5-10% of patients with pancreatic cancer have an underlying germline disorder, while the remaining percentage of cancer cases is thought to be caused by somatic mutations. Some individual studies suggest that mutations in various polymorphic genes can lead to small increases in the risk of pancreatic cancer, but these findings need to be replicated. Rising prevalence of smoking in developing countries, improved diagnosis and increasing population longevity are all likely to increase the global burden of pancreatic cancer in the coming decades.
Similar articles
- Epidemiology of pancreatic cancer: an update.
Maisonneuve P, Lowenfels AB. Maisonneuve P, et al. Dig Dis. 2010;28(4-5):645-56. doi: 10.1159/000320068. Epub 2010 Nov 18. Dig Dis. 2010. PMID: 21088417 Review. - Epidemiologic and etiologic factors of pancreatic cancer.
Lowenfels AB, Maisonneuve P. Lowenfels AB, et al. Hematol Oncol Clin North Am. 2002 Feb;16(1):1-16. doi: 10.1016/s0889-8588(01)00003-x. Hematol Oncol Clin North Am. 2002. PMID: 12063821 Review. - Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
Duell EJ, Casella DP, Burk RD, Kelsey KT, Holly EA. Duell EJ, et al. Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):726-31. doi: 10.1158/1055-9965.EPI-05-0797. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16614115 - Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors.
Klein AP. Klein AP. Nat Rev Gastroenterol Hepatol. 2021 Jul;18(7):493-502. doi: 10.1038/s41575-021-00457-x. Epub 2021 May 17. Nat Rev Gastroenterol Hepatol. 2021. PMID: 34002083 Free PMC article. Review. - Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma.
Stolzenberg-Solomon RZ, Amundadottir LT. Stolzenberg-Solomon RZ, et al. Hematol Oncol Clin North Am. 2015 Aug;29(4):619-40. doi: 10.1016/j.hoc.2015.04.009. Hematol Oncol Clin North Am. 2015. PMID: 26226901 Free PMC article. Review.
Cited by
- Proteomic Investigation of Glyceraldehyde-Derived Intracellular AGEs and Their Potential Influence on Pancreatic Ductal Cells.
Senavirathna L, Ma C, Chen R, Pan S. Senavirathna L, et al. Cells. 2021 Apr 24;10(5):1005. doi: 10.3390/cells10051005. Cells. 2021. PMID: 33923186 Free PMC article. - Heparanase contributes to pancreatic carcinoma progression through insulin-dependent glucose uptake.
Abecassis A, Hermano E, Yifrach A, Popovtzer A, Meirovitz A, Elkin M. Abecassis A, et al. Front Cell Dev Biol. 2023 Nov 22;11:1287084. doi: 10.3389/fcell.2023.1287084. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38078007 Free PMC article. - Duration of diabetes and pancreatic cancer in a case-control study in the Midwest and the Iowa Women's Health Study (IWHS) cohort.
Henry SA, Prizment AE, Anderson KE. Henry SA, et al. JOP. 2013 May 10;14(3):243-9. doi: 10.6092/1590-8577/1317. JOP. 2013. PMID: 23669472 Free PMC article. - Identification of prognostic immune-related lncRNAs in pancreatic cancer.
Ma Y, He X, Di Y, Liu S, Zhan Q, Bai Z, Qiu T, Corpe C, Wang J. Ma Y, et al. Front Immunol. 2022 Nov 7;13:1005695. doi: 10.3389/fimmu.2022.1005695. eCollection 2022. Front Immunol. 2022. PMID: 36420274 Free PMC article. - Cytoplasmic PARP-1 promotes pancreatic cancer tumorigenesis and resistance.
Xu F, Sun Y, Yang SZ, Zhou T, Jhala N, McDonald J, Chen Y. Xu F, et al. Int J Cancer. 2019 Jul 15;145(2):474-483. doi: 10.1002/ijc.32108. Epub 2019 Jan 24. Int J Cancer. 2019. PMID: 30614530 Free PMC article.
References
- J Natl Cancer Inst. 2004 Apr 7;96(7):524-8 - PubMed
- Gastroenterology. 2004 Jun;126(7):1788-94 - PubMed
- Clin Cancer Res. 2009 Jan 15;15(2):740-6 - PubMed
- N Engl J Med. 1993 May 20;328(20):1433-7 - PubMed
- Am J Clin Nutr. 2008 Aug;88(2):431-40 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical